Literature DB >> 179518

Sleep monitoring: the second manned Skylab mission.

J D Frost, W H Shumate, J G Salamy, C R Booher.   

Abstract

The first objective measurements of man's ability to obtain adequate sleep during prolonged space flight were made during the three manned Skylab missions. EEG, EOG, and head-motion signals were acquired during sleep by use of an elastic recording cap containing sponge electrodes and an attached miniature preamplifier/accelerometer unit. A control-panel assembly, mounted in the sleep compartment, tested electrodes, preserved analog signals, and automatically analyzed data in real time (providing a telementered indication of sleep stage). One subject was studied during each manned mission and, while there was considerable variation among individuals, several characteristics were common to all three: stage 3 sleep increased during the flight and decreased in the postflight period; stage 4 was consistently decreased postflight, although this stage was variable during the flight; stage REM (rapid eye movement) was elevated, and REM latency decreased in the late postflight period (after day 3 postrecovery); and the number of awakenings during sleep either showed no change or decreased during the flight. In only the 28-d mission (Skylab 2) was there a significant decrease in total sleep time; in that case it was a result of voluntarily reduced rest time and was not due to difficulty in sleeping nor frequent awakening. The subject on the 84-d mission (Skylab 4) experienced more difficulty in the first half of the flight, showing a decreased total sleep time and increased sleep latency, but this resolved itself with time. Sleep latency presented no problem in the other flights. While many of the findings are statistically significant, in no case would they be expected to produce a noticeable decrement of performance capability. These findings suggest that men are able to obtain adequate sleep in regularly scheduled 8-h rest periods during extended space flights. It seems likely, based upon these results, that the problems encountered in earlier space flights did not arise from the zero-g environment per se but possibly were a result of more restricted living and working areas in the pre-Skylab spacecraft.

Entities:  

Keywords:  NASA Experiment Number M133

Mesh:

Year:  1976        PMID: 179518

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  7 in total

1.  Crewmember performance before, during, and after spaceflight.

Authors:  Thomas H Kelly; Robert D Hienz; Troy J Zarcone; Richard M Wurster; Joseph V Brady
Journal:  J Exp Anal Behav       Date:  2005-09       Impact factor: 2.468

2.  The separate and combined effects of hypoxia and sustained recumbency/inactivity on sleep architecture.

Authors:  Bojan Rojc; Shawnda A Morrison; Ola Eiken; Igor B Mekjavic; Leja Dolenc-Grošelj
Journal:  Eur J Appl Physiol       Date:  2014-06-12       Impact factor: 3.078

Review 3.  On-orbit sleep problems of astronauts and countermeasures.

Authors:  Bin Wu; Yue Wang; Xiaorui Wu; Dong Liu; Dong Xu; Fei Wang
Journal:  Mil Med Res       Date:  2018-05-30

Review 4.  Expedition Cognition: A Review and Prospective of Subterranean Neuroscience With Spaceflight Applications.

Authors:  Nicolette B Mogilever; Lucrezia Zuccarelli; Ford Burles; Giuseppe Iaria; Giacomo Strapazzon; Loredana Bessone; Emily B J Coffey
Journal:  Front Hum Neurosci       Date:  2018-10-30       Impact factor: 3.169

5.  Sleep in space as a new medical frontier: the challenge of preserving normal sleep in the abnormal environment of space missions.

Authors:  Seithikurippu R Pandi-Perumal; Alain A Gonfalone
Journal:  Sleep Sci       Date:  2016-01-20

6.  Substantive nature of sleep in updating the temporal conditions necessary for inducing units of internal sensations.

Authors:  Kunjumon I Vadakkan
Journal:  Sleep Sci       Date:  2016-05-25

7.  Changes in performance and bio-mathematical model performance predictions during 45 days of sleep restriction in a simulated space mission.

Authors:  Erin E Flynn-Evans; Crystal Kirkley; Millennia Young; Nicholas Bathurst; Kevin Gregory; Verena Vogelpohl; Albert End; Steven Hillenius; Yvonne Pecena; Jessica J Marquez
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.